DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2026
    • Delegate Registration
    • Lecture Programme
    • Speakers
    • The DDL Incubator
    • Attending Exhibitors and Sponsors
    • New Researcher Network
    • Hotel and Travel
    • Media Partners
    • Frequently Asked Questions
  • Archive
    • Conference Papers Archive
    • DDL2025
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • EPAG Workshop
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2024
      • Lecture Recordings
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2023
      • Lecture Recordings
      • The Association of Inhalation Toxicologists – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2022
      • Lecture Recordings
      • Academy of Pharmaceutical Sciences – Workshop
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Exhibitors and Sponsors
      • Photo Album
    • DDL2021
      • Conference Papers
      • Lecture Programme
      • Speakers
      • Sponsors
    • Previous Years Conferences
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • The Scientific Advisors
    • Contact
  • Associated Events
    • Annual Aerosol Science Conference
    • RDD 2027
    • USP Workshop
  • The Aerosol Society logo
Matt Bonam

Matt Bonam

Global Head, Biopharma R&D Digital Patient Health, AstraZeneca

During his 19 years at AstraZeneca, Matt has moved through a number of technical line management and project management roles within the business and is currently the Global Head of R&D Digital Patient Health. Matt’s academic background is as a chemist, obtaining his degree at University of Liverpool before moving into the Pharma industry initially as an analytical scientist characterising product performance before moving into project management and project leadership before founding a digital health innovation group within AZ.
The R&D Digital Patient Health group’s mission is to develop digital health solutions which deliver improved clinical outcomes for patients. The group develops tools for use in all phases of the pharmaceutical product lifecycle, delivering its products globally across all therapy areas in which AZ has focus. Having started his career characterising the impact of medication use and misuse on drug delivery Matt is delighted to now be able to deliver tools to patients which robustly improve medication use, collect data directly from patients to support self-management, and improve clinical outcomes.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2026 Drug Delivery to the Lungs Website design: definingdesign.co.uk